Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome
Condition(s):Basal Cell Nevus SyndromeLast Updated:December 18, 2019Withdrawn
Hide Studies Not Open or Pending
Condition(s):Basal Cell Nevus SyndromeLast Updated:December 18, 2019Withdrawn
Condition(s):Basal Cell Nevus SyndromeLast Updated:July 30, 2020Completed
Condition(s):Basal Cell Nevus SyndromeLast Updated:May 31, 2023Terminated
Condition(s):Basal Cell Nevus SyndromeLast Updated:March 8, 2021Completed
Condition(s):Basal Cell Nevus SyndromeLast Updated:July 11, 2017Completed
Condition(s):Basal Cell Carcinoma in Basal Cell Nevus SyndromeLast Updated:February 6, 2023Suspended
Condition(s):Basal Cell Nevus Syndrome; Gorlin SyndromeLast Updated:January 11, 2021Completed
Condition(s):Basal Cell Nevus SyndromeLast Updated:July 23, 2020Completed
Condition(s):Basal Cell Nevus Syndrome; Gorlin’s SyndromeLast Updated:November 2, 2020Completed
Condition(s):Basal Cell Carcinoma; Basal Cell Nevus SyndromeLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.